FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON (VHIO)

Forschungsprojekte

• A Coordination and Support Action to prepare UNCAN.eu platform The 15-month coordination and support action “4.UNCAN.eu” will generate a strategic agenda to launch UNCAN.eu…
• Providing cutting edge cancer research services across Europe canSERVs mission is to make cutting-edge and customised research services available to the cancer research co…
• A European-wide foundation to accelerate Data-driven Cancer Research Cancer complex nature requires integration of advanced research data across national boundaries to enable pro…
• Integrative science, Intelligent data platform for Individualized LUNG cancer care with Immunotherapy Immunotherapy (IO) is the new standard of care for many patients with advanced Non-Small Cell Lung Cancer (aN…
• Data-driven cancer genome interpretation for personalised cancer treatment CGI-Clinics aims at improving personalised medicine in oncology by optimizing genomic data interpretation (af…
• Open Consortium for Decentralized Medical Artificial Intelligence ArtifArtificial Intelligence (AI) will revolutionize healthcare as its diagnostic performance approaches that…
• Unraveling the Functional Complexity of Cancer Genomes through Chromosome Engineering Cancers arise through genetic and epigenetic alterations that drive the transformation of single cells into m…
• CANCER PREVENTION VS CANCER TREATMENT: THE RARE TUMOUR RISK SYNDROMES BATTLE Rare tumour risk syndromes (RTRS) are rare diseases, affecting 5 per 10.000 people or less and caused by heri…
• Pragmatic approach to Adoptive Cell Therapy (ACT) using Tumor Infiltrating Lymphocytes (TIL) in selected solid tumors "The PragmaTIL trial aims to optimize treatment of cancer patients with Tumour-Infiltrating Lymphocytes Adopt…
• A PRECISION MEDICINE TRIAL LEVERAGING BLOOD-BASED TUMOR GENOMICS TO OPTIMIZE TREATMENT IN OPERABLE STAGE III AND HIGH-RISK STAGE II COLON CANCER PATIENTS - THE SAGITTARIUS TRIAL SAGITTARIUS aim to optimize the clinical management of locoregional stage II high-risk/stage III colon cancer…
• PRecisIon Cancer MEdicine RepurpOsing SystEm Using Pragmatic Clinical Trials Millions of people in the EU are negatively affected by cancer, and cancer is one of the leading causes of de…
• COMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPE "Cancer is the second leading cause of death in Europe with an expected increase of about 25% by 2035. A wide…